revenue decline

Microvast ($MVST) plunged 34% after reporting $96.5M revenue (29% below consensus) and 1% gross margins, triggering securities fraud investigation by Pomerantz LLP.

KB Home stock fell 4.8% after Q1 earnings missed expectations, with revenue down 23% year-over-year and operating margins compressed to 3.1%.

C3.ai's CFO sold 15,248 shares for tax purposes, a non-concerning move. However, the stock remains unattractive amid 59.9% decline, CEO departure, and sharp revenue drop.

C3.ai executive chairman sold $4.4M in shares via pre-planned trading arrangement amid 46% revenue decline and CEO transition.

FMC stock faces steep odds reaching $15 amid 5% revenue declines and weak profitability; strategic options being explored.

Bristol Myers Squibb's attractive 4.4% dividend yield faces headwinds from major patent expirations on blockbuster drugs Eliquis and Opdivo.

Schall Law Firm investigates $MVST for alleged securities violations following Q4 results showing 15% revenue decline and gross margin contraction.

Class action lawsuit filed against $ODD alleging material misstatements about advertising partner algorithm changes that devastated customer acquisition costs and Q1 revenue.

ODDITY Tech stock crashed 49.2% after disclosing algorithm changes from major ad partner will slash Q1 2026 revenue by 30%. Securities fraud investigation underway.

Nike and Lululemon shares have plummeted 69% from peaks. Nike boasts unmatched brand strength; Lululemon shows stronger current financials. Both trade at 13-16 year lows.

$ODD stock crashes 49% after revealing 30% Q1 revenue decline tied to advertising partner algorithm shift. Securities lawsuit filed over disclosure failures.

Oddity Tech shares crashed 49% after disclosing algorithm changes from its largest ad partner will trigger 30% Q1 revenue decline, prompting securities fraud investigation.

TEN Holdings reported $3.1M revenues (down 11.4%) and $19.5M net loss in its first year as public company, offset by doubled customer acquisitions and strategic partnerships.

Securities fraud investigation launched against $ALIT following 18.3% and 38.2% stock declines tied to missed revenue guidance and earnings shortfalls in 2025-2026.

FlashEx swung to profitability in 2025 with RMB109.4M net income despite 10.7% revenue decline to RMB3.99B, reflecting cost discipline in competitive market.

ODDITY Tech ($ODD) shares crashed 49% after disclosing 30% Q1 revenue decline tied to advertising partner algorithm change. Securities class action filed.

Johnson Fistel investigates Lifecore Biomedical over 15-18% revenue miss and 18% stock decline, offering shareholder recovery options for alleged securities law violations.

Niu Technologies shares plunged 13.9% after Q4 results revealed 17.4% revenue decline and 68.4% international sales collapse, though management forecasts strong 2026 recovery.

Bumble stock surged 35% on new AI matchmaking features despite Q4 revenue decline of 14.3% and 20.5% paying user drop.

Syra Health slashed net losses 76% to $896K in FY2025 as population health revenue surged 157%, though total revenue fell 9% due to reduced federal funding.